--U.S. FDA Delays: Sanofi is potentially exposed to any delays in reviews due to recently announced staff firings at the U.S. Food and Drug Administration. Its anti-inflammatory drug Dupixent was ...

US biotech major Regeneron Pharmaceuticals has announced a significant expansion of its manufacturing capacity through a new ...

San Diego-based iBio, an AI-driven innovator of precision antibody therapies, has announced a licensing agreement with ...

Sanofi's Sarclisa has been an also-ran in the anti-CD38 antibody class behind Johnson & Johnson and Genmab's blockbuster Darzalex, but now has a chance to steal some of the spotlight. The FDA has ...

vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension and 30% insulin as part injection (rDNA origin) pen fill ...

Following its hugely successful launch in 2019, and with the enthusiasm and support from institutions across the continent, this event recognises outstanding leadership and institutional performance ...

The American Library Association, its 8 divisions, 21 round tables, and offices host many conferences, meetings, forums, institutes, and other events. Use the filters to explore our many available ...